Xu H. Zhang

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

ASO Visual Abstract: Neoadjuvant Chemoimmunotherapy Versus Standard Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.

ASO Visual Abstract: Neoadjuvant Chemoimmunotherapy Versus Standard Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.

Journal: Annals of surgical oncology

Published: August 08, 2026

Neoadjuvant Chemoimmunotherapy Versus Standard Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.

Neoadjuvant Chemoimmunotherapy Versus Standard Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.

Journal: Annals of surgical oncology

Published: March 09, 2026

Multimodal CT and MRI Radiomics Integrated with Clinical Models Predict Pathological Complete Response in ESCC Following Neoadjuvant Immunochemotherapy.

Multimodal CT and MRI Radiomics Integrated with Clinical Models Predict Pathological Complete Response in ESCC Following Neoadjuvant Immunochemotherapy.

Journal: Tomography (Ann Arbor, Mich.)

Published: September 23, 2025

Neoadjuvant chemoimmunotherapy for esophageal squamous cell carcinoma with non-regional cervical lymph node metastasis: a retrospective pilot study.

Neoadjuvant chemoimmunotherapy for esophageal squamous cell carcinoma with non-regional cervical lymph node metastasis: a retrospective pilot study.

Journal: Frontiers in immunology

Published: April 13, 2025

ASO Author Reflections: Anastomotic Leaks as a Surrogate of Biologic Vulnerability in Esophageal Squamous Cell Carcinoma Survival.

ASO Author Reflections: Anastomotic Leaks as a Surrogate of Biologic Vulnerability in Esophageal Squamous Cell Carcinoma Survival.

Journal: Annals of surgical oncology

Published: March 19, 2025

Efficacy evaluation and prognostic prediction of endoscopic ultrasound for neoadjuvant immunotherapy in esophageal cancer.

Efficacy evaluation and prognostic prediction of endoscopic ultrasound for neoadjuvant immunotherapy in esophageal cancer.

Journal: Surgical endoscopy

Published: January 11, 2025

ISCU-p53 axis orchestrates macrophage polarization to dictate immunotherapy response in esophageal squamous cell carcinoma.

ISCU-p53 axis orchestrates macrophage polarization to dictate immunotherapy response in esophageal squamous cell carcinoma.

Journal: Cell death & disease

Published: November 20, 2024

Cholesterol Metabolism-related Characteristics Predict Therapeutic Response and Survival in Esophageal Cancer.

Cholesterol Metabolism-related Characteristics Predict Therapeutic Response and Survival in Esophageal Cancer.

Journal: Journal of advanced research

Published: November 11, 2024

Impact of Anastomotic Leaks on Long-Term Survival in Patients with Esophageal Squamous Cell Carcinoma Following McKeown Esophagectomy: A Propensity Score-Matched Analysis.

Impact of Anastomotic Leaks on Long-Term Survival in Patients with Esophageal Squamous Cell Carcinoma Following McKeown Esophagectomy: A Propensity Score-Matched Analysis.

Journal: Annals of surgical oncology

Published: October 08, 2024

Younger women with esophageal carcinoma exhibit improved prognosis after esophagectomy: a single-center, high-volume cohort study.

Younger women with esophageal carcinoma exhibit improved prognosis after esophagectomy: a single-center, high-volume cohort study.

Journal: BMC cancer

Published: September 29, 2024

Case report: Watch-and-wait strategy in resectable esophageal cancer following neoadjuvant chemoimmunotherapy: a case series.

Case report: Watch-and-wait strategy in resectable esophageal cancer following neoadjuvant chemoimmunotherapy: a case series.

Journal: Frontiers in immunology

Published: September 26, 2024

CCL5hi Macrophages Interact with CD8+ T Cells and Potentiate Responsiveness to PD-1 Blockade Plus Chemotherapy in Esophageal Squamous Cell Carcinoma.

CCL5hi Macrophages Interact with CD8+ T Cells and Potentiate Responsiveness to PD-1 Blockade Plus Chemotherapy in Esophageal Squamous Cell Carcinoma.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: August 05, 2024

Showing 1-12 of 44

Last Updated: 09/26/2026